• 名称：Luseogliflozin
• 简介：Luseogliflozin is an orally active second-generation sodium-glucose co-transporter 2 (SGLT2) inhibitor developed by Taisho Pharmaceutical for the treatment of patients with type 2 diabetes mellitus (T2DM).
• CASNO：898537-18-3
• 分子式：C23H30O6S
• 分子量：434.55
• SMILES：CCOC1=CC=C(C=C1)CC2=C(C=C(C(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](S3)CO)O)O)O)OC)C
• 保持条件：at -20°C 3 years Powder
• 同名：TS 071, TS071, TS-71
• 纯度：>98%
• 应用：SGLT2 Inhibitor
• 作用机制：Inhibitor